Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLC vs MRNA✓SelectedUSD · MRNAXLC vs MRNA performance historyLatest closeAs of-2.66%11/20
Stock and ETF performance explorer

XLC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-13.3%
MRNA return
+323.5%
Excess return
-336.9%
Maximum drawdown
-13.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.7%-2.2%-0.5%-2.6%
7D-8.0%-12.7%+4.7%-7.8%
30D-8.2%-20.7%+12.5%-8.0%
3M-9.3%+46.3%-55.6%-9.6%
6M-13.3%+305.2%-318.6%-14.3%
All-13.3%+323.5%-336.9%-14.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling